Athens, Greece

Konstantinos Anastasios Kagkadis

This inventor holds 1 USPTO granted patent. Top assignee: Vianex S.a.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Konstantinos Anastasios Kagkadis. Retrieved from https://idiyas.com/inventor/konstantinos-anastasios-kagkadis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Konstantinos Anastasios Kagkadis

Introduction

Konstantinos Anastasios Kagkadis is a notable inventor based in Athens, Greece. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inclusion complexes that enhance the solubility of important compounds.

Latest Patents

Kagkadis holds a patent for an "Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin." This invention relates to a method for producing a 2-hydroxypropyl-beta-cyclodextrin inclusion complex of taxol. The method involves admixing the 2-hydroxypropyl-beta-cyclodextrin with taxol at a molar ratio of 1-1000 times with respect to taxol. Additionally, the invention includes a method for improving the solubility of taxol, which consists of dissolving taxol in ethanol, dissolving 2-hydroxypropyl-beta-cyclodextrin in water, and then admixing the two solutions. The patent highlights the potential for enhanced solubility of taxol, which is crucial for its therapeutic applications.

Career Highlights

Kagkadis is associated with Vianex S.A., a prominent pharmaceutical company in Greece. His work at Vianex has allowed him to focus on innovative solutions that address challenges in drug solubility and delivery.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Konstantinos Anastasios Kagkadis is a distinguished inventor whose work on the inclusion complex of taxol has the potential to significantly impact the pharmaceutical industry. His contributions reflect a commitment to advancing medical science through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…